ENDRA Life Sciences (NDRA) Construction in Progress (2019 - 2024)
ENDRA Life Sciences (NDRA) posted quarterly Construction in Progress of $125153.0 for Q3 2024, down 11.0% year-over-year from $140617.0 in Q4 2023, and little changed quarter-over-quarter from $125151.0 in Q2 2024.
ENDRA Life Sciences (NDRA) Construction in Progress (2019 - 2024) Analysis & Trends
ENDRA Life Sciences (NDRA) has reported Construction in Progress for 6 consecutive years, with $125153.0 the latest figure, recorded in Q3 2024.
- In Q3 2024, Construction in Progress fell 11.0% year-over-year to $125153.0; the TTM figure through Sep 2024 stood at $125153.0 (down 11.0% YoY), while the FY2023 annual figure was $125151.0, down 11.0% from the prior year.
- Construction in Progress steadied at $125153.0 in Q3 2024 per NDRA's latest filing, from $125151.0 in the prior quarter.
- Across five years, Construction in Progress topped out at $143482.0 in Q2 2022 and bottomed at $79207.0 in Q4 2020.
- Historically, Construction in Progress has averaged $126508.4 across 5 years, with a median of $125153.0 in 2024.
- Annual changes were most pronounced in 2020 — Construction in Progress surged 81.68% — and 2023, when it retreated 11.0%.
- ENDRA Life Sciences' Construction in Progress stood at $79207.0 in 2020, then jumped by 35.95% to $107682.0 in 2021, then surged by 30.59% to $140617.0 in 2022, then decreased by 11.0% to $125151.0 in 2023, then climbed by 0.0% to $125153.0 in 2024.
- Business Quant data shows NDRA's Construction in Progress at $125153.0 in Q3 2024, $125151.0 in Q2 2024, and $125151.0 in Q1 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Construction in Progress (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 234.15 Bn | 230.09 Bn | 8.34 Bn | - |
| 2 | Danaher | 152.10 Bn | 147.75 Bn | 3.61 Bn | - |
| 3 | Natera | 48.48 Bn | 47.38 Bn | 486.15 Mn | - |
| 4 | Agilent Technologies | 44.35 Bn | 42.55 Bn | 990.00 Mn | - |
| 5 | Iqvia Holdings | 43.68 Bn | 41.60 Bn | 1.44 Bn | - |
| 6 | Idexx Laboratories | 43.02 Bn | 42.83 Bn | 779.09 Mn | - |
| 7 | Illumina | 34.39 Bn | 33.22 Bn | 770.00 Mn | - |
| 8 | Mettler Toledo International | 28.29 Bn | 28.24 Bn | 650.22 Mn | - |
| 9 | Labcorp Holdings | 27.51 Bn | 27.37 Bn | 1.11 Bn | - |
| 10 | ENDRA Life Sciences | 7.16 Mn | 1.62 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2024 | 125,153.00 |
| Jun 30, 2024 | 125,151.00 |
| Mar 31, 2024 | 125,151.00 |
| Dec 31, 2023 | 125,151.00 |
| Sep 30, 2023 | 140,617.00 |
| Jun 30, 2023 | 140,617.00 |
| Mar 31, 2023 | 140,617.00 |
| Dec 31, 2022 | 140,617.00 |
| Sep 30, 2022 | 143,482.00 |
| Jun 30, 2022 | 143,482.00 |
| Mar 31, 2022 | 107,682.00 |
| Dec 31, 2021 | 107,682.00 |
| Dec 31, 2020 | 79,207.00 |
| Dec 31, 2019 | 43,596.00 |